Assessment of Structural Intolerance and Durability
General Structure Information 2leo SPINK7 solution structure of esophageal cancer-related gene 2 -1.0Å AUTH Y.FENG,Y.GENG,T.ZHOU,J.WANGTITL NMR STRUCTURE NOTE: HUMAN ESOPHAGEAL CANCER-RELATED GENE 2REF J.BIOMOL.NMR V. 53 65 2012REFN ISSN 0925-2738PMID 22528291DOI 10.1007/S10858-012-9622-9 Variant Set Distributions Mapped Variants
General Structure Information 1unl CDK5 structural mechanism for the inhibition of cd5-p25 from the roscovitine, aloisine and indirubin. 2.2Å AUTH M.MAPELLI,L.MASSIMILINAO,C.CROVACE,M.A.SEELIGER,L.-H.TSAI,AUTH 2 L.MEIJER,A.MUSACCHIOTITL MECHANISM OF CDK5/P25 BINDING BY CDK INHIBITORSREF J.MED.CHEM. V. 48 671 2005REFN ISSN 0022-2623PMID 15689152DOI 10.1021/JM049323M Variant Set Distributions Mapped Variants
General Structure Information 4f52 RBX1 structure of a glomulin-rbx1-cul1 complex 3.0Å AUTH D.M.DUDA,J.L.OLSZEWSKI,A.E.TRON,M.HAMMEL,L.J.LAMBERT,AUTH 2 M.B.WADDELL,T.MITTAG,J.A.DECAPRIO,B.A.SCHULMANTITL STRUCTURE OF A GLOMULIN-RBX1-CUL1 COMPLEX: INHIBITION OF ATITL 2 RING E3 LIGASE THROUGH MASKING OF ITS E2-BINDING SURFACE.REF MOL.CELL V. 47 371 2012REFN ISSN 1097-2765PMID 22748924DOI 10.1016/J.MOLCEL.2012.05.044 Variant Set Distributions Mapped Variants
General Structure Information 2pon BCL2L1 solution structure of the bcl-xl/beclin-1 complex -1.0Å AUTH W.FENG,S.HUANG,H.WU,M.ZHANGTITL MOLECULAR BASIS OF BCL-XLS TARGET RECOGNITIONTITL 2 VERSATILITY REVEALED BY THE STRUCTURE OF BCL-XL INTITL 3 COMPLEX WITH THE BH3 DOMAIN OF BECLIN-1.REF J.MOL.BIOL. V. 372 223 2007REFN ISSN 0022-2836PMID 17659302DOI 10.1016/J.JMB.2007.06.069 Variant Set Distributions Mapped Variants
General Structure Information 4bgg ACVR1 crystal structure of the acvr1 kinase in complex with ldn-213844 2.56Å AUTH A.H.MOHEDAS,Y.WANG,C.E.SANVITALE,P.CANNING,S.CHOI,X.XING,AUTH 2 A.N.BULLOCK,G.D.CUNY,P.B.YUTITL STRUCTURE-ACTIVITY RELATIONSHIP OF 3,5-DIARYL-2-TITL 2 AMINOPYRIDINE ALK2 INHIBITORS REVEALS UNALTERED BINDINGTITL 3 AFFINITY FOR FIBRODYSPLASIA OSSIFICANS PROGRESSIVA CAUSINGTITL 4 MUTANTS.REF J.MED.CHEM. V. 57 7900 2014REFN ISSN 0022-2623PMID 25101911DOI 10.1021/JM501177W Variant Set Distributions Ripley’s K Analysis […]
General Structure Information 2qyn PDE4D crystal structure of pde4d2 in complex with inhibitor npv 1.57Å AUTH H.WANG,M.S.PENG,Y.CHEN,J.GENG,H.ROBINSON,AUTH 2 M.D.HOUSLAY,J.CAI,H.KETITL STRUCTURES OF THE FOUR SUBFAMILIES OFTITL 2 PHOSPHODIESTERASE-4 PROVIDE INSIGHT INTO THETITL 3 SELECTIVITY OF THEIR INHIBITORS.REF BIOCHEM.J. V. 408 193 2007REFN ISSN 0264-6021PMID 17727341DOI 10.1042/BJ20070970 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons […]
General Structure Information 2nyl PPP2R5C crystal structure of protein phosphatase 2a (pp2a) holoenzyme with the catalytic subunit carboxyl terminus truncated 3.8Å AUTH Y.XU,Y.XING,Y.CHEN,Y.CHAO,Z.LIN,E.FAN,J.W.YU,S.STRACK,AUTH 2 P.D.JEFFREY,Y.SHITITL STRUCTURE OF THE PROTEIN PHOSPHATASE 2A HOLOENZYME.REF CELL(CAMBRIDGE,MASS.) V. 127 1239 2006REFN ISSN 0092-8674PMID 17174897DOI 10.1016/J.CELL.2006.11.033 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Mapped Variants
General Structure Information 4ark MAP2K1 crystal structure of the catalytic domain of human map kinase kinase 1 (mek1) in complex with a small molecule inhibitor and adp 2.6Å AUTH I.V.HARTUNG,M.HITCHCOCK,F.PUEHLER,R.NEUHAUS,A.SCHOLZ,AUTH 2 S.HAMMER,K.PETERSEN,G.SIEMEISTER,D.BRITTAIN,R.C.HILLIGTITL OPTIMIZATION OF ALLOSTERIC MEK INHIBITORS – PART 1:TITL 2 VENTURING INTO UNEXPLORED SAR TERRITORIESREF BIOORG.MED.CHEM.LETT. V. 23 2384 2013REFN ISSN 0960-894XPMID 23474388DOI 10.1016/J.BMCL.2013.02.028 […]
General Structure Information 3qx3 TOP2B human topoisomerase iibeta in complex with dna and etoposide 2.16Å AUTH C.C.WU,T.K.LI,L.FARH,L.Y.LIN,T.S.LIN,Y.J.YU,T.J.YEN,AUTH 2 C.W.CHIANG,N.L.CHANTITL STRUCTURAL BASIS OF TYPE II TOPOISOMERASE INHIBITION BY THETITL 2 ANTICANCER DRUG ETOPOSIDEREF SCIENCE V. 333 459 2011REFN ISSN 0036-8075PMID 21778401DOI 10.1126/SCIENCE.1204117 Variant Set Distributions Ripley’s K Analysis Plots Variant Set Comparisons Pathogenic Proximity Analysis Mapped […]
General Structure Information 3vw9 GLO1 human glyoxalase i with an n-hydroxypyridone inhibitor 1.47Å AUTH T.CHIBA,J.OHWADA,H.SAKAMOTO,T.KOBAYASHI,T.A.FUKAMI,M.IRIE,AUTH 2 T.MIURA,K.OHARA,H.KOYANOTITL DESIGN AND EVALUATION OF AZAINDOLE-SUBSTITUTEDTITL 2 N-HYDROXYPYRIDONES AS GLYOXALASE I INHIBITORSREF BIOORG.MED.CHEM.LETT. V. 22 7486 2012REFN ISSN 0960-894XPMID 23122816DOI 10.1016/J.BMCL.2012.10.045 Variant Set Distributions Mapped Variants